Lewis Asset Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-3,902
Closed -$350K 181
2025
Q1
$350K Buy
3,902
+833
+27% +$77.8K 0.29% 90
2024
Q4
$305K Buy
3,069
+250
+9% +$25.8K 0.23% 97
2024
Q3
$320K Buy
2,819
+641
+29% +$76.2K 0.23% 102
2024
Q2
$270K Buy
2,178
+54
+3% +$6.96K 0.21% 104
2024
Q1
$280K Buy
2,124
+103
+5% +$12.7K 0.23% 93
2023
Q4
$220K Buy
+2,021
New +$210K 0.2% 100

Other funds holding MRK

Lewis Asset Management's MRK Position: Q2 2025 in Review

Lewis Asset Management sold out of Merck (MRK) in Q2 2025, closing a stake of 3,902 shares — an estimated $350K sold.

Lewis Asset Management first reported a position in MRK in Q4 2023 and held it in 6 quarters. The position peaked at $350K in Q1 2025. 3,327 funds tracked by Wall St. Rank hold MRK as of Q2 2025.

  • Lewis Asset Management reported no remaining Merck position as of Q2 2025 after selling out during the quarter.
  • Lewis Asset Management sold 3,902 Merck shares in Q2 2025, an estimated $350K.
  • Lewis Asset Management first reported a position in Merck in Q4 2023 and held it in 6 quarters.
  • Lewis Asset Management's Merck position peaked at $350K in Q1 2025.
  • 3,327 funds tracked by Wall St. Rank held Merck as of Q2 2025.

Based on Lewis Asset Management's 13F filing for Q2 2025, filed 14 Jul 2025.